Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells.

Saved in:
Bibliographic Details
Title: Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells.
Authors: Coelho SC; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465 Porto, Portugal. silvia.coelho@fe.up.pt., Reis DP; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465 Porto, Portugal. reis.danielp@gmail.com., Pereira MC; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465 Porto, Portugal. mcsp@fe.up.pt., Coelho MAN; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465 Porto, Portugal. mcoelho@fe.up.pt.
Source: Pharmaceutics [Pharmaceutics] 2018 Jul 12; Vol. 10 (3). Date of Electronic Publication: 2018 Jul 12.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1999-4923
DOI:10.3390/pharmaceutics10030091